Use of enteric polymers for production of microspheres by extrusion-spheronization

Pharmaceutica Acta Helvetiae

Volumn 72, Issue 3, 1997, Pages 145-152

  Varshosaz, J ^a,b   Kennedy, R A ^a   Gipps, E M ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Enteric coating; Extrusion spheronization; Matrix type microspheres; Phenylbutazone; Wurster air suspension

Indexed keywords

CELLACEFATE; EUDRAGIT; HYDROXYPROPYLMETHYLCELLULOSE PHTHALATE; LACTOSE; MACROGOL; MICROCRYSTALLINE CELLULOSE; MICROSPHERE; PHENYLBUTAZONE; POLYMER;

ARTICLE; DRUG COATING; DRUG MANUFACTURE; DRUG RELEASE; ENTERIC COATED TABLET; IN VITRO STUDY; PARTICLE SIZE; SPHERONIZATION; TECHNIQUE;

EID: 0030954517     PISSN: 00316865     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0031-6865(97)00005-8     Document Type: Article

References (15)

1. Baert, L., Vermeersch, H., Remon, J.P., Smeyers-Verbeke, J. and Massart, D.L. (1993) Study the parameters important in the spheronisation process. Int. J. Pharm. 96, 225-229.
2. Elbers, J.A.C., Bakkenes, H.W. and Fokkens, J.G. (1992) Effect of amount and composition of granulation liquid on mixing, extrusion and spheronization. Drug Dev. Ind. Pharm. 18(5), 501-517.
3. Eskilson, C. (1985) Controlled release by microencapsulation. Manuf. Chem. 56(3), 33-39.
4. Fonner, Jr., D.E., Banker, G.S. and Swarbrick, J. (1966) Micromeritics of granular pharmaceutical solids I. Physical properties of particles prepared by five different granulation methods. J. Pharm. Sci. 55, 181-186.
5. Funck, J.A.B., Schwartz, J.B., Reilly, W.J. and Ghali, E.S. (1991) Binder effectiveness for beads with high drug levels. Drug Dev. Ind. Pharm. 17(9), 1143-1156.
6. Goskonda, S.R. and Upadrashta, S.M. (1993) Avicel RC-591/ Chitosan beads by extrusion-spheronization technology. Drug Dev. Ind. Pharm. 19(8), 915-927.
7. Hellen, L., Yliruusi, J. and Kristoffersson, E. (1993a) Process variables of instant granulator and spheroniser: I. Physical properties of granules, extrudate and pellets. Int. J. Pharm. 96, 197-204.
8. Hellen, L., Yliruusi, J. and Kristoffersson, E. (1993b) Process variables of instant granulator and spheroniser: II. Size and size distributions of pellets. Int. J. Pharm. 96, 205-216.
9. Ku, C.C., Joshi, Y.M., Bergum, J.S. and Jain, N.B. (1993) Bead manufacture by extrusion-spheronization. A statistical design for process optimization. Drug Dev. Ind. Pharm. 19(13), 1505-1519.
10. Lachman, L., Lieberman, H.A. and Kanig, J.L. (1986) The Theory and Practice of Industrial Pharmacy. Lea and Febiger, Philadelphia.
11. Lindner, H. and Kleinebudde, P. (1994) Use of powdered cellulose for the production of pellets by extrusion/spheronization. J. Pharm. Pharmacol. 46, 2-7.
12. Mesiha, M.S. and Valles, J. (1993) A screening study of lubricants in wet powder masses suitable for extrusion-spheronization. Drug Dev. Ind. Pharm. 19(8), 943-959.
13. Nakahara, N. (1966) U.S. Patent, 3, 277, 520, in: I. Ghebre-Sellasie (Ed.), Pharmaceutical Pelletization Technology. Marcel Dekker, New York, 1989.
14. Reynolds, A.D. (1970) A new technique for the production of spherical particles. Manuf. Chem. 41(6), 40-43.
15. Tarcha, P.J. (1991) Polymers for Controlled Drug Delivery. CRC Press, Boca Raton, Florida.